High-content screening is a powerful method to discover new drugs and carry out basic biological research. Increasingly, high-content screens have come to rely on supervised machine learning (SML) to perform automatic phenotypic classification as an essential step of the analysis. However, this comes at a cost, namely, the labeled examples required to train the predictive model. Classification performance increases with the number of labeled examples, and because labeling examples demands time from an expert, the training process represents a significant time investment. Active learning strategies attempt to overcome this bottleneck by presenting the most relevant examples to the annotator, thereby achieving high accuracy while minimizing t...
High-content, imaging-based screens now routinely generate data on a scale that precludes manual ver...
High-content, imaging-based screens now routinely generate data on a scale that precludes manual ver...
MOTIVATION: Many biomedical projects would benefit from reducing the time and expense of in vitro ex...
There has been an increase in the use of machine learning and artificial intelligence (AI) for the a...
There has been an increase in the use of machine learning and artificial intelligence (AI) for the a...
There has been an increase in the use of machine learning and artificial intelligence (AI) for the a...
<p>BACKGROUND: Drug discovery and development has been aided by high throughput screening methods th...
High-content screening (HCS) uses computational analysis on large collections of unlabeled biologica...
High-content screening (HCS) uses computational analysis on large collections of unlabeled biologica...
AbstractIn supervised learning it is assumed that it is straightforward to obtain labeled data. Howe...
Complex mixtures containing natural products are still an interesting source of novel drug candidate...
High-content, imaging-based screens now routinely generate data on a scale that precludes manual ver...
High-content, imaging-based screens now routinely generate data on a scale that precludes manual ver...
We investigate the following data mining problem from Computational Chemistry: From a large data set...
MOTIVATION: Many biomedical projects would benefit from reducing the time and expense of in vitro ex...
High-content, imaging-based screens now routinely generate data on a scale that precludes manual ver...
High-content, imaging-based screens now routinely generate data on a scale that precludes manual ver...
MOTIVATION: Many biomedical projects would benefit from reducing the time and expense of in vitro ex...
There has been an increase in the use of machine learning and artificial intelligence (AI) for the a...
There has been an increase in the use of machine learning and artificial intelligence (AI) for the a...
There has been an increase in the use of machine learning and artificial intelligence (AI) for the a...
<p>BACKGROUND: Drug discovery and development has been aided by high throughput screening methods th...
High-content screening (HCS) uses computational analysis on large collections of unlabeled biologica...
High-content screening (HCS) uses computational analysis on large collections of unlabeled biologica...
AbstractIn supervised learning it is assumed that it is straightforward to obtain labeled data. Howe...
Complex mixtures containing natural products are still an interesting source of novel drug candidate...
High-content, imaging-based screens now routinely generate data on a scale that precludes manual ver...
High-content, imaging-based screens now routinely generate data on a scale that precludes manual ver...
We investigate the following data mining problem from Computational Chemistry: From a large data set...
MOTIVATION: Many biomedical projects would benefit from reducing the time and expense of in vitro ex...
High-content, imaging-based screens now routinely generate data on a scale that precludes manual ver...
High-content, imaging-based screens now routinely generate data on a scale that precludes manual ver...
MOTIVATION: Many biomedical projects would benefit from reducing the time and expense of in vitro ex...